Free Gift With Purchase & Free Shipping - Limited Time! Shop Now
The Opioid Epidemic Has Created New Challenges for Clinicians and Chronic Pain Patients<sup>1</sup>

The Opioid Epidemic Has Created New Challenges for Clinicians and Chronic Pain Patients1

  • 84% of patients believe there is a stigma around opioid use
  • 42% admitted it has impacted how they communicate with their doctor about their pain
  • 90% of chronic pain patients are looking for new treatment option
Clinically Proven Technology - 100% Drug Free

Clinically Proven Technology - 100% Drug Free

Quell has been shown in multiple clinical studies to relieve chronic pain. Quell uses high frequency nerve stimulation to block pain signals in the body. The mechanism of action is thought to be activation of central inhibition and a decrease in central excitation. In a study published in the Journal of Pain Research, 81% of Quell users reported an improvement in chronic pain.2

In a published study, 67% of users reported a decrease in pain medication use2

Designed for people with a wide range of chronic pain conditions

Quell has FDA 510(k) clearance for the treatment of chronic pain. It may be used 24/7, so your patients can use the device during the day while active and at night while sleeping. In multiple clinical studies, Quell was shown to provide relief from chronic pain in the feet, legs and lower back. Additionally, Nerve stimulation, such as by Quell, can have widespread effects that provide pain relief beyond the site of stimulation.

How It Works

Quell uses prescription-strength nerve stimulation technology to block chronic pain. Worn just below the knee, Quell electrically stimulates sensory afferents from dermatomes S2 – L4. Nerve stimulation can provide a widespread response that blocks pain signals beyond the site of stimulation. To learn more, download the Quell Whitepaper.

Quell, an innovative approach to pain relief

  • Available without prescription
  • Up to 10x more powerful than typical OTC TENS devices.3
  • No major side effects
  • Powered by the Quell Relief App which allows patients to personalize therapy and track usage, sleep, activity, gait and pain levels over time.
  1. Neurometrix/Vanson Bourne Research Survey of 1500 Chronic Pain Patients
  2. Journal of Pain Research 2016;(9):469-479. Based on 60 days of product use. Results may vary.
  3. Comparison to leading OTC TENS devices, based on retail sales data. Maximum sustained energy when used as directed.
Benefits Quell® Technology OTC TENS Devices OTC Pain Meds[a] Other
Prescription Pain Meds[b]
Prescription
Opioid Pain Meds[c]
Treats Chronic Pain +/- +/-
Widespread Effects [d]  
Nighttime Pain Relief  
No Major Side Effects      
No Addiction Potential +/-  
Smartphone Enabled +/-      
Digital Health Integration        
Available without Prescription    

Benefits

Treats Chronic Pain
Widespread Effects [d]
Nighttime Pain Relief
No Major Side Effects
No Addiction Potential
Smartphone Enabled
Digital Health Integration
Available without Prescription
Treats Chronic Pain
Widespread Effects [d]
 
Nighttime Pain Relief
 
No Major Side Effects
No Addiction Potential
Smartphone Enabled
Digital Health Integration
 
Available without Prescription
Treats Chronic Pain
Widespread Effects [d]
Nighttime Pain Relief
No Major Side Effects
 
No Addiction Potential
Smartphone Enabled
 
Digital Health Integration
 
Available without Prescription
Treats Chronic Pain
Widespread Effects [d]
Nighttime Pain Relief
No Major Side Effects
 
No Addiction Potential
Smartphone Enabled
 
Digital Health Integration
 
Available without Prescription
 
Treats Chronic Pain
Widespread Effects [d]
Nighttime Pain Relief
No Major Side Effects
 
No Addiction Potential
 
Smartphone Enabled
 
Digital Health Integration
 
Available without Prescription
 
  1. Non-steroidal anti-inflammatory drugs, acetaminophen, aspirin, etc.
  2. Gabapentin, pregabalin, duloxetine, amitriptyline, etc.
  3. Hydrocodone, oxycodone, meperidine, etc.
  4. Nerve stimulation, such as by Quell, can have widespread effects that provide pain relief beyond the site of stimulation.

Clinical Data and the Science Behind Quell

Selected posters and abstracts

Levels and Predictors of Activity in Users of Wearable Neurostimulators with Chronic Pain.

American Academy of Pain Medicine Annual Meeting, April 2018

Dose-Response of Surface Neurostimulation in Chronic Pain

American Pain Society Scientific Summit, March 2018

Pilot of Sleep/Wake Classification by Leg-Worn Actigraphy.

Abstract to American Academy of Neurology Annual Meeting, April 2018

Quell Band
Get in touch with us or call 800.204.6577

Sign me up for the latest news on Quell